Disclosing the potential of eleganolone for Parkinson’s disease therapeutics: neuroprotective and anti-inflammatory activities

The treatment of Parkinson´s disease (PD) has benefited from significant advances resulting from the increasing research efforts focused on new therapeutics. However, the current treatments for PD are mostly symptomatic, alleviating disease symptoms without reversing or retarding disease progression...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva, Joana (author)
Outros Autores: Alves, Celso (author), Pinteus, Susete (author), Susano, Patrícia (author), Simões, Marco (author), Guedes, Miguel (author), Martins, Alice (author), Rehfeldt, Stephanie (author), Gaspar, Helena (author), Goettert, Márcia Inês (author), Alfonso, Amparo (author), Pedrosa, Rui (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
Apoptosis
Diterpenes
Marine natural products
NF-kB pathway
Neurodegenerative diseases
Oxidative stress
Texto completo:http://hdl.handle.net/10400.8/5996
País:Portugal
Oai:oai:iconline.ipleiria.pt:10400.8/5996

Texto Completo

http://hdl.handle.net/10400.8/5996

Registros relacionados